isoflurane has been researched along with Cardiac Remodeling, Ventricular in 9 studies
Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compared to isoflurane and s-ketamine, xenon limited progressive adverse cardiac remodeling and contractile dysfunction 28 days after perioperative myocardial infarction." | 7.79 | Xenon and isoflurane reduce left ventricular remodeling after myocardial infarction in the rat. ( Becker, MM; Bleilevens, C; Funcke, S; Goetzenich, A; Hein, M; Roehl, AB; Rossaint, R; Steendijk, P, 2013) |
| " The heart rhythm was monitored continuously and ventricular arrhythmias were treated with amiodarone and cardioversion." | 5.12 | Decreased mortality in a rat model of acute postinfarction heart failure. ( Lorentzon, M; Omerovic, E; Råmunddal, T, 2006) |
| " Chronic injection with the β-adrenoceptor (β-AR) agonist isoproterenol (ISO) has been commonly used as an animal model of β-AR-induced cardiac remodelling and heart failure." | 3.80 | Echocardiographic assessment of β-adrenoceptor stimulation-induced heart failure with reduced heart rate in mice. ( Chen, C; Li, H; Lu, ZZ; Song, Y; Xiao, H; Zhang, YY, 2014) |
| "Compared to isoflurane and s-ketamine, xenon limited progressive adverse cardiac remodeling and contractile dysfunction 28 days after perioperative myocardial infarction." | 3.79 | Xenon and isoflurane reduce left ventricular remodeling after myocardial infarction in the rat. ( Becker, MM; Bleilevens, C; Funcke, S; Goetzenich, A; Hein, M; Roehl, AB; Rossaint, R; Steendijk, P, 2013) |
| "Pompe's disease is an autosomal recessive and often fatal condition, caused by mutations in the acid alpha-glucosidase gene, leading to lysosomal glycogen storage in heart and skeletal muscle." | 1.31 | Cardiac remodeling and contractile function in acid alpha-glucosidase knockout mice. ( Duncker, DJ; Kamphoven, JH; Reuser, AJ; Stubenitsky, R; Van Der Ploeg, AT; Verdouw, PD, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meng, T | 1 |
| Ren, X | 1 |
| Chen, X | 1 |
| Yu, J | 1 |
| Agrimi, J | 1 |
| Paolocci, N | 1 |
| Gao, WD | 1 |
| Li, H | 1 |
| Lu, ZZ | 1 |
| Chen, C | 1 |
| Song, Y | 1 |
| Xiao, H | 1 |
| Zhang, YY | 1 |
| Dyballa-Rukes, N | 1 |
| Schuh, C | 1 |
| Vogt, H | 1 |
| Toma, O | 1 |
| Schlack, WS | 1 |
| Weber, NC | 1 |
| Metzger, S | 1 |
| Roehl, AB | 1 |
| Funcke, S | 1 |
| Becker, MM | 1 |
| Goetzenich, A | 1 |
| Bleilevens, C | 1 |
| Rossaint, R | 1 |
| Steendijk, P | 1 |
| Hein, M | 1 |
| Råmunddal, T | 1 |
| Lorentzon, M | 1 |
| Omerovic, E | 1 |
| Feng, J | 2 |
| Fischer, G | 3 |
| Lucchinetti, E | 3 |
| Zhu, M | 2 |
| Bestmann, L | 1 |
| Jegger, D | 1 |
| Arras, M | 1 |
| Pasch, T | 1 |
| Perriard, JC | 1 |
| Schaub, MC | 2 |
| Zaugg, M | 3 |
| Jamnicki, M | 1 |
| Zaugg, K | 1 |
| Kamphoven, JH | 1 |
| Stubenitsky, R | 1 |
| Reuser, AJ | 1 |
| Van Der Ploeg, AT | 1 |
| Verdouw, PD | 1 |
| Duncker, DJ | 1 |
1 trial available for isoflurane and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Decreased mortality in a rat model of acute postinfarction heart failure.
Topics: Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Critical Care; Diseas | 2006 |
8 other studies available for isoflurane and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Anesthetic Agents Isoflurane and Propofol Decrease Maximal Ca
Topics: Anesthetics; Animals; Ca(2+) Mg(2+)-ATPase; Calcium; Female; Heart Failure; Isoflurane; Male; Myocar | 2019 |
Echocardiographic assessment of β-adrenoceptor stimulation-induced heart failure with reduced heart rate in mice.
Topics: Adrenergic beta-Agonists; Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Echocardiography | 2014 |
In vivo desflurane preconditioning evokes dynamic alterations of metabolic proteins in the heart--proteomic insights strengthen the link between bioenergetics and cardioprotection.
Topics: Anesthetics, Inhalation; Animals; Chromatography, High Pressure Liquid; Desflurane; Electrophoresis, | 2014 |
Xenon and isoflurane reduce left ventricular remodeling after myocardial infarction in the rat.
Topics: Anesthetics, Inhalation; Animals; Cardiotonic Agents; Disease Models, Animal; Electrocardiography; I | 2013 |
Infarct-remodeled myocardium is receptive to protection by isoflurane postconditioning: role of protein kinase B/Akt signaling.
Topics: Anesthetics, Inhalation; Animals; Blotting, Western; Cardiotonic Agents; Hemodynamics; In Vitro Tech | 2006 |
Preconditioning by isoflurane retains its protection against ischemia-reperfusion injury in postinfarct remodeled rat hearts.
Topics: Anesthetics, Inhalation; Animals; Cardiotonic Agents; Chromones; Coronary Vessels; Decanoic Acids; D | 2008 |
Cardiac remodelling hinders activation of cyclooxygenase-2, diminishing protection by delayed pharmacological preconditioning: role of HIF1 alpha and CREB.
Topics: Active Transport, Cell Nucleus; Animals; Blotting, Western; Cardiovascular Agents; Colorimetry; Cycl | 2008 |
Cardiac remodeling and contractile function in acid alpha-glucosidase knockout mice.
Topics: alpha-Glucosidases; Anesthetics, Inhalation; Animals; Cardiomyopathy, Hypertrophic; Dobutamine; Gluc | 2001 |